Antiviral drugs are different from antibiotics. Flu antiviral drugs are different from antiviral drugs used to treat other infectious diseases such as COVID-19. Antiviral drugs prescribed to treat COVID-19 are not approved or authorized to treat flu.[1]
List of Antiviral Drugs!Antiviral!Use!Manufacturer!Component!Type!Year approvedAbacavir | HIV | ViiV Healthcare | | Nucleoside analogue reverse transcriptase inhibitor (NRTI) | 1998 |
Acyclovir (Aciclovir) | Herpes Simplex, chickenpox,[2] varicella zoster virus | | | guanosine analogue RTI | 1981 |
Adefovir | Hepatitis B[3] | Gilead Sciences | | RTI | 2002 (FDA), 2003 (EU) |
Amantadine | Influenza | | | Influenza A virus M2 proton channel antagonist | |
Ampligen | Avian Influenza | | | | |
Amprenavir (Agenerase) | HIV | | | Protease inhibitor (PI) | |
Umifenovir (Arbidol) | Influenza | | | Hemagglutinin inhibitor | |
Atazanavir | HIV | | | PI | |
Atripla (Efavirenz/emtricitabine/tenofovir) | HIV | | | - Efavirenz: Non-nucleoside RTI (NNRTI)
- Emtricitabine: NRTI
- Tenofovir disoproxil: NRTI
| |
Baloxavir marboxil (Xofluza)[4] | Influenza A/B | | | Cap snatching endonuclease inhibitor | 2018 |
Biktarvy (Bictegravir/emtricitabine/tenofovir alafenamide) | HIV | | | - Bictegravir: INSTI
- Emtricitabine: NRTI
- Tenofovir alafenamide: NRTI
| |
Boceprevir | Hepatitis C genotype 1[5] | Schering-Plough, then Merck Group | | Protease inhibitor | - FDA approved 2011
- Withdrawn 2015
|
Bulevirtide | Hepatitis D/B | | | Sodium/bile acid cotransporter inactivator | |
Cidofovir | AIDS | | | Viral DNA Polymerase inhibitor | |
Cobicistat (Tybost)[6] | HIV | | | human CYP3A protein inhibitor | |
Combivir (Lamivudine/Zidovudine) | HIV | | |
| |
Daclatasvir (Daklinza) | Hepatitis C | | | NS5A inhibitor | |
Darunavir | HIV | | antiretroviral | HIV PI | |
Delavirdine | HIV | | antiretroviral | NNRTI | |
Descovy (Emtricitabine/tenofovir alafenamide) | Hepatitis B | | | - Emtricitabine: NRTI
- Tenofovir alafenamide: NRTI
| |
Didanosine | HIV | | | Adenosine analogue RTI | |
Docosanol | Herpes Simplex | | | Entry inhibitor | |
Dolutegravir | HIV | | | Integrase inhibitor | |
Doravirine (Pifeltro)[7] | HIV | | | NNRTI | |
Edoxudine | Herpes Simplex | | | Thymidine analogue inhibitor | |
Efavirenz | HIV | Mylan | | NNRTI | 1998 |
Elvitegravir | HIV | Gilead Sciences | | Integrase inhibitor |
|
Emtricitabine | HIV | Gilead Sciences | | NRTI | 2003 |
Enfuvirtide | HIV | | | Entry inhibitor | 2003 |
Ensitrelvir | COVID-19 | Shionogi | | 3C-like protease inhibitor | |
Entecavir | HIV | | | NRTI | 2005 |
Etravirine (Intelence)[8] | HIV | | | NNRTI | 2008 |
Famciclovir | Herpes Zoster | | | Guanosine analogue | 1994 |
Fomivirsen | AIDS | | Anti-sense oligonucleotide | Anti-sense | - FDA-licensed in 1998
- Withdrawn in EU (2002), US (2006)
|
Fosamprenavir | HIV | ViiV Healthcare | | Amprenavir pro-drug | 2003 (FDA), 2004 (EMA) |
Foscarnet | Herpes | | | Pyrophosphate analogue DNA polymerase inhibitor | 1991 |
Ganciclovir (Cytovene)[9] | Cytomegalovirus (CMV)[10] | | | Competitive nucleoside analogue dGTP inhibitor | 1988 |
Ibacitabine | Herpes labialis | | | | |
Ibalizumab (Trogarzo)[11] | HIV | | | Entry inhibitor | 2018 |
Idoxuridine | Herpes | | | dU analogue inhibitor | 1962 |
Imiquimod | Genital wart, Basal cell carcinoma, Actinic keratosis | | | Opioid growth factor receptor (OGFr) agonist | 1997 |
Inosine pranobex | Herpes Simplex | | | Thymus hormone immunostimulant | |
Indinavir | HIV | | | PI | 1996 |
Lamivudine | HIV | | | cytidine analogue RTI | |
Letermovir (Prevymis)[12] | Cytomegalovirus (CMV) | | | | |
Lopinavir | HIV | | | | |
Loviride | HIV | | | | |
Maraviroc | HIV | | | entry inhibitor | |
Methisazone | Smallpox | | | | |
Molnupiravir | COVID-19 | | | viral RNA polymerase inhibitor | |
Moroxydine | Influenza | | | | |
Nelfinavir | HIV | | | | |
Nirmatrelvir/ritonavir (Paxlovid) | COVID-19 | Pfizer | | 3C-like protease inhibitor (Nirmatrelvir) / inhibition of metabolism of nirmatrelvir (ritonavir) | |
Nevirapine | HIV | | | non-nucleoside reverse transcriptase inhibitor | |
Nitazoxanide | Broad-spectrum antiviral | | thiazolide | | |
Norvir | HIV | | | | |
Oseltamivir (Tamiflu)[13] | Influenza | | | neuraminidase inhibitor | |
Peramivir (Rapivab)[14] | Influenza | | | | |
Penciclovir | Herpes | | | | |
Pleconaril | Picornavirus | Schering-Plough | | | |
Podophyllotoxin | Genital wart | | | | |
Raltegravir | HIV | | | Integrase inhibitor | |
Remdesivir | COVID-19 | | | viral RNA polymerase inhibitor | |
Ribavirin | Hepatitis C[15] | | | nucleoside analogue reverse transcriptase inhibitor | |
Rilpivirine (Edurant)[16] | HIV | | | | |
Rimantadine | Influenza A | | | M2 proton channel antagonist | |
Ritonavir | HIV | | | HIV-1 protease inhibitor | |
Saquinavir | HIV | | | | |
Simeprevir (Olysio) | Hepatitis C | | | | |
Sofosbuvir | Hepatitis C[17] | | | nucleoside analogue reverse transcriptase inhibitor | |
Stavudine | HIV | | | | |
Taribavirin (Viramidine) | Hepatitis Syndromes in which Ribavirin is active[18] | | | | |
Telaprevir | Hepatitis C | | | | |
Telbivudine (Tyzeka) | Hepatitis B | | | | |
Tenofovir alafenamide | Hepatitis B | | | | |
Tenofovir disoproxil | Hepatitis B, HIV[19] | | | | |
Tipranavir | HIV | | | | |
Trifluridine | Eyes related Herpes | | | | |
Trizivir | HIV | | | | |
Tromantadine | Herpes Simplex | | | | |
Truvada | HIV | | | | |
Umifenovir | Influenza | | | | |
Valaciclovir (Valtrex)[20] | Herpes Simplex/Zoster | | | | |
Valganciclovir (Valcyte)[21] | Cytomegalovirus (CMV) | | | | |
Vicriviroc | HIV-1 | Schering-Plough | | pyrimidine CCR5 entry inhibitor | |
Vidarabine | Herpes Simplex, Varicella Zoster | | | | |
Zalcitabine | HIV | | | | |
Zanamivir (Relenza)[22] | Influenza A, Influenza B | | | | |
Zidovudine | HIV[23] | | Antiretroviral | | | |